The Complement C1q (C1q) Antibodies, Serum test detects IgG autoantibodies directed against the C1q component of the complement system, an important part of the body's immune defense mechanism. Anti-C1q antibodies are associated with certain autoimmune and inflammatory disorders, particularly lupus-related kidney disease.
Why is this Test Ordered?
This test may be recommended for:
Evaluation of Systemic Lupus Erythematosus (SLE)
Assessment of Lupus Nephritis (kidney involvement in lupus)
Investigation of Hypocomplementemic Urticarial Vasculitis Syndrome (HUVS)
Monitoring disease activity in autoimmune disorders
Evaluation of unexplained low complement levels
Specimen Required
Sample Type: Serum
Container: Plain Red Top / Serum Separator Tube (SST)
Patient Preparation: No special preparation required
Clinical Significance
Anti-C1q antibodies bind to the C1q protein and can activate the classical complement pathway, leading to inflammation and tissue damage. Elevated levels are commonly associated with:
Systemic Lupus Erythematosus (SLE)
Active Lupus Nephritis
Hypocomplementemic Urticarial Vasculitis
Certain infectious conditions such as HIV and Hepatitis C infections
Interpretation of Results
Result
Interpretation
<20 U/mL
Negative
20–39 U/mL
Weak Positive
40–80 U/mL
Moderate Positive
>80 U/mL
Strong Positive
A positive result supports the presence of anti-C1q antibodies but should always be interpreted along with clinical findings and other laboratory tests such as C3 and C4 complement levels.
Symptoms That May Prompt Testing
Persistent rash or hives
Joint pain and swelling
Kidney disease symptoms
Blood in urine
Unexplained inflammation
Suspected autoimmune disease
Reporting Time
Approximately 3–7 working days (may vary by laboratory).
SEO Meta Description
Complement C1q (C1q) Antibodies, Serum test measures autoantibodies against C1q to aid in the diagnosis and monitoring of lupus nephritis, systemic lupus erythematosus (SLE), and hypocomplementemic urticarial vasculitis. #Dermafact #gynofact